CN104771595A - 一种增强免疫力的中药组合物及其制备方法 - Google Patents
一种增强免疫力的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN104771595A CN104771595A CN201510128318.2A CN201510128318A CN104771595A CN 104771595 A CN104771595 A CN 104771595A CN 201510128318 A CN201510128318 A CN 201510128318A CN 104771595 A CN104771595 A CN 104771595A
- Authority
- CN
- China
- Prior art keywords
- fructus ligustri
- ligustri lucidi
- radix astragali
- alcohol extraction
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 103
- 230000036039 immunity Effects 0.000 title claims abstract description 53
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 197
- 238000000605 extraction Methods 0.000 claims abstract description 173
- 239000003814 drug Substances 0.000 claims abstract description 58
- 238000003809 water extraction Methods 0.000 claims abstract description 57
- 238000001035 drying Methods 0.000 claims abstract description 26
- 235000006533 astragalus Nutrition 0.000 claims abstract description 22
- 241001061264 Astragalus Species 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 210000004233 talus Anatomy 0.000 claims abstract description 19
- 239000009636 Huang Qi Substances 0.000 claims description 130
- 239000000843 powder Substances 0.000 claims description 76
- 238000000034 method Methods 0.000 claims description 65
- 239000007788 liquid Substances 0.000 claims description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 50
- 239000006228 supernatant Substances 0.000 claims description 39
- 239000000284 extract Substances 0.000 claims description 36
- 230000008569 process Effects 0.000 claims description 30
- 238000010992 reflux Methods 0.000 claims description 19
- 239000006071 cream Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 16
- 238000001291 vacuum drying Methods 0.000 claims description 16
- 238000004108 freeze drying Methods 0.000 claims description 9
- 230000004087 circulation Effects 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000007902 hard capsule Substances 0.000 claims description 4
- 239000007901 soft capsule Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 240000005373 Panax quinquefolius Species 0.000 abstract description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 10
- 230000003014 reinforcing effect Effects 0.000 abstract description 8
- 230000000259 anti-tumor effect Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 5
- 241001076416 Dendrobium tosaense Species 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 230000004071 biological effect Effects 0.000 abstract description 3
- 238000005303 weighing Methods 0.000 abstract description 2
- 230000028327 secretion Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 79
- 241000699670 Mus sp. Species 0.000 description 39
- 239000000243 solution Substances 0.000 description 35
- 241000699666 Mus <mouse, genus> Species 0.000 description 33
- 238000004458 analytical method Methods 0.000 description 31
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 238000003304 gavage Methods 0.000 description 24
- 150000004676 glycans Chemical class 0.000 description 24
- 229920001282 polysaccharide Polymers 0.000 description 24
- 239000005017 polysaccharide Substances 0.000 description 24
- 230000000694 effects Effects 0.000 description 21
- 230000000242 pagocytic effect Effects 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 19
- 238000000540 analysis of variance Methods 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- 206010018910 Haemolysis Diseases 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 230000008588 hemolysis Effects 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 14
- 230000007812 deficiency Effects 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- 238000013459 approach Methods 0.000 description 12
- 238000000556 factor analysis Methods 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 11
- 238000009826 distribution Methods 0.000 description 11
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 10
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 10
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 10
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 10
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 229940100243 oleanolic acid Drugs 0.000 description 10
- 235000019353 potassium silicate Nutrition 0.000 description 10
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 10
- 239000013558 reference substance Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 10
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 9
- 239000012567 medical material Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000036737 immune function Effects 0.000 description 8
- 238000007689 inspection Methods 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 241000287828 Gallus gallus Species 0.000 description 6
- 101000981253 Mus musculus GPI-linked NAD(P)(+)-arginine ADP-ribosyltransferase 1 Proteins 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 6
- 239000012980 RPMI-1640 medium Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000006285 cell suspension Substances 0.000 description 6
- 239000012531 culture fluid Substances 0.000 description 6
- 235000008434 ginseng Nutrition 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 230000034994 death Effects 0.000 description 5
- 210000001508 eye Anatomy 0.000 description 5
- 239000012467 final product Substances 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 210000003024 peritoneal macrophage Anatomy 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- 230000007306 turnover Effects 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000000205 computational method Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000007405 data analysis Methods 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 108010006464 Hemolysin Proteins Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 230000003064 anti-oxidating effect Effects 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- -1 ether terpenoid Chemical class 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000003228 hemolysin Substances 0.000 description 3
- 239000000976 ink Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 206010029410 night sweats Diseases 0.000 description 3
- 230000036565 night sweats Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010010144 Completed suicide Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 208000007117 Oral Ulcer Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 208000018685 gastrointestinal system disease Diseases 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 210000001616 monocyte Anatomy 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 238000012803 optimization experiment Methods 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000282452 Ailuropoda melanoleuca Species 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 102000016917 Complement C1 Human genes 0.000 description 1
- 108010028774 Complement C1 Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000026010 Dendrobium candidum Species 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000208367 Euonymus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034016 Paronychia Diseases 0.000 description 1
- 241000029132 Paronychia Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 240000001085 Trapa natans Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021168 barbecue Nutrition 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000009583 hair follicle growth Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000002664 nootropic agent Substances 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 125000000955 oleanolic acid group Chemical group 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000009165 saligot Nutrition 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008542 thermal sensitivity Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
剂量(g/kg*bw) | 动物数(只) | 耳壳增重(mg) | P值 |
0 | 12 | 12.7±3.8 | |
0.3 | 12 | 15.2±4.8 | 0.438 |
0.6 | 12 | 15.6±5.1 | 0.293 |
1.2 | 12 | 17.9±3.5 | 0.017 |
剂量(g/kg*bw) | 动物数(只) | HC50 | P值 |
0 | 12 | 46±27 | |
0.3 | 12 | 60±29 | 0.419 |
0.6 | 12 | 73±31 | 0.270 |
1.2 | 12 | 82±23 | 0.006 |
剂量(g/kg*bw) | 动物数(只) | 吞噬指数a | P值 |
0 | 12 | 5.09±0.68 | |
0.3 | 12 | 5.18±0.76 | 0.993 |
0.6 | 12 | 5.23±0.79 | 0.937 |
1.2 | 12 | 5.52±0.92 | 0.738 |
剂量(g/kg*bw) | 动物数(只) | 吞噬百分率(%) | P值 | 吞噬指数 | P值 |
0 | 12 | 15.2±5.4 | 0.6±0.04 | ||
0.3 | 12 | 16.3±6.3 | 0.823 | 0.21±0.07 | 0.367 |
0.6 | 12 | 16.7±5.5 | 0.847 | 0.19±0.04 | 0.932 |
1.2 | 12 | 21.4±6.8 | 0.041 | 0.27±0.09 | 0.031 |
剂量(g/kg*bw) | 动物数(只) | NK细胞活性(%) | P值 |
0 | 12 | 28.3±13.9 | |
0.3 | 12 | 42.9±18.7 | 0.39 |
0.6 | 12 | 44.7±20.3 | 0.053 |
1.2 | 12 | 45.3±15.7 | 0.057 |
组别 | 动物数(只) | HC50 | P值 |
对照组 | 12 | 47±26 | |
A组 | 12 | 62±27 | 0.421 |
B组 | 12 | 70±28 | 0.265 |
C组 | 12 | 75±32 | 0.286 |
D组 | 12 | 81±22 | 0.007 |
E组 | 12 | 67±24 | 0.256 |
F组 | 12 | 64±28 | 0.395 |
G组 | 12 | 72±30 | 0.273 |
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510128318.2A CN104771595B (zh) | 2015-03-23 | 2015-03-23 | 一种增强免疫力的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510128318.2A CN104771595B (zh) | 2015-03-23 | 2015-03-23 | 一种增强免疫力的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104771595A true CN104771595A (zh) | 2015-07-15 |
CN104771595B CN104771595B (zh) | 2018-11-16 |
Family
ID=53613578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510128318.2A Active CN104771595B (zh) | 2015-03-23 | 2015-03-23 | 一种增强免疫力的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104771595B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107156830A (zh) * | 2017-04-26 | 2017-09-15 | 丽江久康生物科技有限公司 | 一种增强免疫力的组合物、其制备方法和应用 |
CN110742270A (zh) * | 2019-09-24 | 2020-02-04 | 海南葫芦娃药业集团股份有限公司 | 一种增强免疫力保健食品及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002255845A (ja) * | 2001-02-20 | 2002-09-11 | Kenzen Kyu | 消渇湯 |
CN1621083A (zh) * | 2003-11-28 | 2005-06-01 | 甘肃扶正药物科技股份有限公司 | 贞芪扶正药物制备方法改进 |
CN102178848A (zh) * | 2011-05-04 | 2011-09-14 | 湖南龙石山铁皮石斛基地有限公司 | 一种中药铁皮石斛制剂及其制备方法 |
-
2015
- 2015-03-23 CN CN201510128318.2A patent/CN104771595B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002255845A (ja) * | 2001-02-20 | 2002-09-11 | Kenzen Kyu | 消渇湯 |
CN1621083A (zh) * | 2003-11-28 | 2005-06-01 | 甘肃扶正药物科技股份有限公司 | 贞芪扶正药物制备方法改进 |
CN102178848A (zh) * | 2011-05-04 | 2011-09-14 | 湖南龙石山铁皮石斛基地有限公司 | 一种中药铁皮石斛制剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
金国梁等: "《防癌抗癌中药》", 31 August 2001, 上海科学技术出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107156830A (zh) * | 2017-04-26 | 2017-09-15 | 丽江久康生物科技有限公司 | 一种增强免疫力的组合物、其制备方法和应用 |
CN110742270A (zh) * | 2019-09-24 | 2020-02-04 | 海南葫芦娃药业集团股份有限公司 | 一种增强免疫力保健食品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104771595B (zh) | 2018-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100374538C (zh) | 五脏滋补酒及其制备工艺 | |
CN104435775A (zh) | 一种中药保健酒及其制备方法 | |
CN104288501A (zh) | 一种降糖颗粒及其制备方法 | |
CN108904563B (zh) | 一种全株人参原浆加工方法及用途 | |
CN102379949A (zh) | 四逆散制备工艺 | |
CN104305205B (zh) | 一种提高免疫力的菟丝子口服液及其制备方法 | |
CN105724642A (zh) | 一种抗氧化抗衰老的黑茶组合物及制备方法 | |
CN106177053A (zh) | 一种包含青钱柳叶和陈皮的降血糖保健组合物 | |
CN102247479B (zh) | 一种抗肿瘤壮药及其制备方法 | |
CN103749818A (zh) | 一种黄精降糖降脂保健茶及其制备方法 | |
CN101780242B (zh) | 一种保健或药品组合物及其制备方法和用途 | |
CN103520318B (zh) | 一种增强免疫功能的中药组合物及其制备方法 | |
CN106177432A (zh) | 一种包含青钱柳叶、桑叶、绿茶和玉竹的保健组合物 | |
CN104998083A (zh) | 一种增强免疫力的中药组合物及其制备方法与应用 | |
CN106177477A (zh) | 一种用于降血糖、降血脂和降血压的保健组合物 | |
CN104771595A (zh) | 一种增强免疫力的中药组合物及其制备方法 | |
CN106109521A (zh) | 一种三七口服液 | |
CN106215118A (zh) | 抗肿瘤的保健制剂及其制备方法 | |
CN106109840A (zh) | 明目地黄丸及其制备方法 | |
CN102233089B (zh) | 一种用于更年期综合症的中药组合物及其制备方法 | |
CN106177476A (zh) | 一种包含石斛和陈皮的降血糖保健组合物 | |
CN104306784A (zh) | 一种用于治疗风湿性关节炎的中药组合物及其制备方法和应用 | |
CN104069455B (zh) | 预防及治疗肝癌的药物及其制备方法 | |
CN105998448A (zh) | 提高免疫力的桑葚口服液制备方法及其口服液 | |
CN106237128A (zh) | 延缓衰老的菟丝子口服液制备方法及其口服液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240624 Address after: 530228 plot 6, Mucun Po, Mucun village, Suwei Town, Jiangnan District, Nanning City, Guangxi Zhuang Autonomous Region business site: plot behind the office of Mucun village committee, Suwei Town, Jiangnan District, Nanning City Patentee after: Guangxi nongfengshan Dendrobium officinale Technology Co.,Ltd. Country or region after: China Address before: 530221 Nanning, Yinhai, the Guangxi Zhuang Autonomous Region, west of the Yinhai Road, 708-1 Shang Shang garden 3 rooms, 306 rooms. Patentee before: GUANGXI LONGFENGSHAN BIOTECHNOLOGY CO.,LTD. Country or region before: China |